Evrotrust is a leading European provider of remote digital identity, electronic signatures, and compliance solutions certified at the highest level under EU eIDAS regulation. As an EU‑notified electronic identification scheme, Evrotrust enables legally recognized remote identity verification for users from more than 60 nationalities, allowing organizations to replace in‑person processes with fully digital, compliant workflows. By assuming legal responsibility for identity verification and operating under strict regulatory supervision, Evrotrust provides a high‑assurance trust layer backed by substantial professional liability coverage.

Within the life sciences and healthcare ecosystem, Evrotrust plays a critical role in enabling digital‑first, patient‑centric clinical research. Its services are particularly well suited for clinical trials and decentralized or hybrid trial models, where secure remote interactions, auditability, and regulatory compliance are essential. Evrotrust supports key clinical trial processes such as investigator onboarding, patient identification, informed consent, and document execution without requiring physical presence, helping sponsors, CROs, and sites accelerate trial timelines while reducing operational burden.

A core use case is electronic informed consent (eConsent), where Evrotrust provides legally binding qualified electronic signatures, qualified timestamps, and secure electronic delivery. These capabilities ensure that consent is obtained from verified participants, time‑stamped, tamper‑evident, and fully traceable—meeting the expectations of ethics committees, regulators, and inspectors. This makes Evrotrust particularly suitable for decentralized trials, remote patient enrollment, and cross‑border studies where traditional paper‑based consent is impractical or slow. Beyond eConsent, Evrotrust enables trusted digital workflows across the clinical trial lifecycle through remote identity verification, qualified electronic seals for system‑generated documents, and timestamping of critical events such as data entry, amendments, and database lock. These services strengthen data integrity and support compliance with GCP, CFR Part 11, Annex 11, GDPR, and eIDAS requirements, while providing clear audit trails for inspections and long‑term archiving. Designed with an API‑first architecture, Evrotrust integrates seamlessly into eCRF, eTMF, and clinical trial platforms, allowing trust services to be embedded directly into existing systems and user journeys. This enables life sciences organizations to scale securely across multiple studies and geographies, supporting both enterprise and public‑sector use cases.

Through its combination of high‑assurance identity, legally recognized digital signatures, and healthcare‑ready trust services, Evrotrust serves as a reliable foundation for modern, decentralized, and compliant clinical research and the evolving digital clinical trials landscape.